KRSNAA DIAGNOSTICS
Back to All Ratios
|
KRSNAA DIAGNOSTICS Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2023 | Mar2022 | |
---|---|---|
Core EBITDA Growth(%) | -3.22 | - |
What is the latest Core EBITDA Growth ratio of KRSNAA DIAGNOSTICS ?
Year | Core EBITDA Growth |
---|---|
Mar2023 | -3.22 |
Mar2022 | - |
How is Core EBITDA Growth of KRSNAA DIAGNOSTICS Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2023 | -3.22 | 0 | |
Mar2022 | 0 | - |
Other Financial Ratios of KRSNAA DIAGNOSTICS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of KRSNAA DIAGNOSTICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KRSNAA DIAGNOSTICS | ₹1,888.1 Cr | 3.6% | -7.4% | 17.1% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹86,400.2 Cr | -4% | -6.9% | 31.8% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹79,176.8 Cr | 1.5% | 0% | 77.6% | Stock Analytics | |
GLOBAL HEALTH | ₹37,886.4 Cr | -2.5% | 6.1% | 177% | Stock Analytics | |
FORTIS HEALTHCARE | ₹34,101.5 Cr | 1.8% | 5.5% | 69.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,542.0 Cr | -2% | -3.4% | 65.4% | Stock Analytics |
KRSNAA DIAGNOSTICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KRSNAA DIAGNOSTICS | 3.6% |
-7.4% |
17.1% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses